Your browser doesn't support javascript.
Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19.
Sparks, Rachel; Lau, William W; Liu, Can; Han, Kyu Lee; Vrindten, Kiera L; Sun, Guangping; Cox, Milann; Andrews, Sarah F; Bansal, Neha; Failla, Laura E; Manischewitz, Jody; Grubbs, Gabrielle; King, Lisa R; Koroleva, Galina; Leimenstoll, Stephanie; Snow, LaQuita; Chen, Jinguo; Tang, Juanjie; Mukherjee, Amrita; Sellers, Brian A; Apps, Richard; McDermott, Adrian B; Martins, Andrew J; Bloch, Evan M; Golding, Hana; Khurana, Surender; Tsang, John S.
  • Sparks R; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Lau WW; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Liu C; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Han KL; Graduate Program in Biological Sciences, University of Maryland, College Park, MD, USA.
  • Vrindten KL; NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.
  • Sun G; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Cox M; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Andrews SF; Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA.
  • Bansal N; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Failla LE; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.
  • Manischewitz J; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Grubbs G; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • King LR; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.
  • Koroleva G; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.
  • Leimenstoll S; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.
  • Snow L; NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.
  • Chen J; Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD, USA.
  • Tang J; Johns Hopkins University, Baltimore, MD, USA.
  • Sellers BA; NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.
  • Apps R; Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA.
  • McDermott AB; NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.
  • Martins AJ; NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.
  • Bloch EM; NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA.
  • Golding H; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA.
  • Khurana S; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.
  • Tsang JS; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Nature ; 614(7949): 752-761, 2023 02.
Article in English | MEDLINE | ID: covidwho-2185939
ABSTRACT
Acute viral infections can have durable functional impacts on the immune system long after recovery, but how they affect homeostatic immune states and responses to future perturbations remain poorly understood1-4. Here we use systems immunology approaches, including longitudinal multimodal single-cell analysis (surface proteins, transcriptome and V(D)J sequences) to comparatively assess baseline immune statuses and responses to influenza vaccination in 33 healthy individuals after recovery from mild, non-hospitalized COVID-19 (mean, 151 days after diagnosis) and 40 age- and sex-matched control individuals who had never had COVID-19. At the baseline and independent of time after COVID-19, recoverees had elevated T cell activation signatures and lower expression of innate immune genes including Toll-like receptors in monocytes. Male individuals who had recovered from COVID-19 had coordinately higher innate, influenza-specific plasmablast, and antibody responses after vaccination compared with healthy male individuals and female individuals who had recovered from COVID-19, in part because male recoverees had monocytes with higher IL-15 responses early after vaccination coupled with elevated prevaccination frequencies of 'virtual memory'-like CD8+ T cells poised to produce more IFNγ after IL-15 stimulation. Moreover, the expression of the repressed innate immune genes in monocytes increased by day 1 to day 28 after vaccination in recoverees, therefore moving towards the prevaccination baseline of the healthy control individuals. By contrast, these genes decreased on day 1 and returned to the baseline by day 28 in the control individuals. Our study reveals sex-dimorphic effects of previous mild COVID-19 and suggests that viral infections in humans can establish new immunological set-points that affect future immune responses in an antigen-agnostic manner.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / T-Lymphocytes / Sex Characteristics / Vaccination / COVID-19 / Immunity, Innate / Immunologic Memory Type of study: Prognostic study Topics: Vaccines Limits: Female / Humans / Male Language: English Journal: Nature Year: 2023 Document Type: Article Affiliation country: S41586-022-05670-5

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / T-Lymphocytes / Sex Characteristics / Vaccination / COVID-19 / Immunity, Innate / Immunologic Memory Type of study: Prognostic study Topics: Vaccines Limits: Female / Humans / Male Language: English Journal: Nature Year: 2023 Document Type: Article Affiliation country: S41586-022-05670-5